Direct Selling Self-Regulatory Council Recommends Elomir Discontinue Certain Earnings and Health-Related Product Claims
McLean, VA – December 12, 2023 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs recommended that Elomir, Inc. modify or discontinue certain earnings and health-related product performance claims, including disease treatment claims for its Axis Klärity product.
The advertising claims were made by Elomir, a multi-level marketing company that sells nutritional supplements, and its salesforce members. The inquiry was brought to DSSRC by a non-governmental advocacy group (NGO).
The challenged product performance claims include, but are not limited to:
- “Axis Klärity helps to promote healthy joints, a mellow mood, focus and mental clarity and gut health”
- “… blood sugar support, cognitive support, immune support; mood support; focus and clarity; stimulant free energy; stress relief; gut health”
- “Emotional? Overwhelmed? Anxious? Foggy head? Feeling heavy?” / Image of testimonial with copy stating “the first time I took the strip was on a very emotionally charged day and honestly within 5 minutes the feeling of heaviness and overwhelm drifted away! I feel so inspired, have amazing clarity, feeling happy and my focus is zen like yet so sharp every time!”
- “When you have stomach issues from years of stress, ulcers, and GERD, you look for ways to get your supplements into your system by bypassing your tummy. I just tried @Elomir Corporate #axisklarity and I am in love! Not sure what #NAC #curcumin or #bvitaminsforenergy do for your body? You’ll want to search it up! My chiropractor has had me taking these supplements for months to combat #inflammation & to help my fight off viruses. This strip is phenomenal! 💛🌻🌟 #gastricbypasscommunity #gastricbypassjourney #weightlossjouney #bariatriclife #bariatricbabe #bariatriccommunity #healthsupplements #bounty”
- “Guess who beat DIABETES 🙌🏼 Unexpected news from my doctor this week! He asked what did I do differently. He was amazed by what I showed him 🟨 #diabetes #beatdiabetes.”
- “What I have noticed that improved since being on Axis Klarity: better mood; better focus; better skin, no breakouts because my gut health is better; better sleep.”
Challenged earnings claims include, but are not limited to:
- “Whether you want the chance to earn a little extra income to help pay your bills or build a long-term home-based business, the possibilities await you at ELOMIR.”
- “#buildingmyretirment”
- “multiple 7 figures [in commissions” and claims such as “[p]ay off 3 of our credit cards,” and “paid our house note”
Elomir participated in the DSSRC process in good faith and worked quickly to remove most of the earnings and health-related claims identified by the NGO, more than 70 claims. In at least five instances where a salesforce member was unresponsive to Elomir’s request to take down the claim, Elomir commented directly on the social media post to state that it contains unsubstantiated earnings or medical claims.
After a thorough review of substantiation provided for the remaining health-related claims in question, DSSRC determined that though the evidence submitted outlines the promise or positive benefits of the individual ingredients contained in Elomir’s flagship product, Axis Klärity, the substantiation is insufficient to support the wide-ranging health-related product performance claims challenged in this inquiry.
As a result, DSSRC recommended that Elomir discontinue the remaining challenged claims.
Regarding the earnings claim “Earn a little extra income to help pay your bills and build a home-based business. We allow you to be your own boss and provide you with the compensation plan to help you meet your goals,” which remains available on the Elomir website, DSSRC remained concerned that such claim in the context presented on the reasonably conveys that the typical salesforce member may earn significant income through the Elomir business opportunity and recommended it be removed from the website.
DSSRC appreciates Elomir for their ongoing efforts to remove or modify the rest of the claims from circulation.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of DSSRC decisions, visit the DSSRC Cases and Closures webpage.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims
McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.
Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action
McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.
Children’s Advertising Review Unit Recommends JustPlay Discontinue or Modify Daisy the Yoga Goat Claims
New York, NY – December 19, 2024 - The Children’s Advertising Review Unit (CARU) launched an investigation into advertising for Just Play’s furReal Daisy the Yoga Goat seeking to determine if the toy’s product packaging and commercial advertisements comply with CARU’s Self-Regulatory Guidelines for Children’s Advertising.
In National Advertising Division Fast-Track SWIFT Challenge, Oral Essentials Voluntarily Modifies “Made in USA” Claims
New York, NY – December 19, 2024 – In a National Advertising Division challenge, Oral Essentials agreed to permanently modify its claim that certain Oral Essentials oral healthcare products are “Made in USA.”